J. Neil Duncan

545 total citations
14 papers, 433 citations indexed

About

J. Neil Duncan is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. Neil Duncan has authored 14 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. Neil Duncan's work include Receptor Mechanisms and Signaling (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). J. Neil Duncan is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). J. Neil Duncan collaborates with scholars based in United States, Sweden and United Kingdom. J. Neil Duncan's co-authors include Martin Smith, Iain Martin, Guodong Zhang, Karthik Srinivasan, Jian Lin, Rita M. Huff, Shibing Deng, Michael W. Dunne, Anthony A. Fossa and Todd Wisialowski and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

J. Neil Duncan

14 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Neil Duncan United States 10 215 132 90 49 43 14 433
Suman Rakhit United States 17 237 1.1× 367 2.8× 57 0.6× 38 0.8× 21 0.5× 27 635
Alan Stobie United Kingdom 15 241 1.1× 349 2.6× 66 0.7× 35 0.7× 23 0.5× 34 552
Shane Roller United States 12 143 0.7× 92 0.7× 62 0.7× 65 1.3× 11 0.3× 24 359
Pamela A. Chambers United States 10 149 0.7× 113 0.9× 80 0.9× 10 0.2× 19 0.4× 16 336
David A. Carcache Switzerland 13 193 0.9× 187 1.4× 47 0.5× 36 0.7× 17 0.4× 19 408
T. Ladduwahetty United States 11 288 1.3× 339 2.6× 92 1.0× 16 0.3× 21 0.5× 15 642
Vittorio Pestellini Italy 11 270 1.3× 191 1.4× 227 2.5× 15 0.3× 28 0.7× 36 485
Gregory J. Pacofsky United States 11 165 0.8× 210 1.6× 28 0.3× 17 0.3× 17 0.4× 14 616
Clare O. Kneen United Kingdom 12 346 1.6× 385 2.9× 199 2.2× 34 0.7× 42 1.0× 21 735
Deborah A. Evrard United States 13 272 1.3× 398 3.0× 91 1.0× 40 0.8× 34 0.8× 15 567

Countries citing papers authored by J. Neil Duncan

Since Specialization
Citations

This map shows the geographic impact of J. Neil Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Neil Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Neil Duncan more than expected).

Fields of papers citing papers by J. Neil Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Neil Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Neil Duncan. The network helps show where J. Neil Duncan may publish in the future.

Co-authorship network of co-authors of J. Neil Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Neil Duncan. A scholar is included among the top collaborators of J. Neil Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Neil Duncan. J. Neil Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Duncan, J. Neil, et al.. (2017). Calculation of a permitted daily exposure value for the solvent 2-methyltetrahydrofuran. Regulatory Toxicology and Pharmacology. 87. 54–63. 17 indexed citations
2.
Deneka, Alexander Y., Samuel Litwin, J. Neil Duncan, et al.. (2015). Abstract 1731: Preclinical testing demonstrates strong activity of STA-12-8666, an HSP90 inhibitor-SN-38 conjugate, in small cell lung cancer (SCLC). Cancer Research. 75(15_Supplement). 1731–1731. 1 indexed citations
3.
Walker, Don K., Deepak Dalvie, John D. Davis, et al.. (2009). A Holistic Strategy for Characterizing the Safety of Metabolites through Drug Discovery and Development. Chemical Research in Toxicology. 22(10). 1653–1662. 44 indexed citations
4.
Zhang, Guodong, et al.. (2007). Strategies for Bioanalysis of an Oligonucleotide Class Macromolecule from Rat Plasma Using Liquid Chromatography−Tandem Mass Spectrometry. Analytical Chemistry. 79(9). 3416–3424. 67 indexed citations
5.
Fossa, Anthony A., Todd Wisialowski, J. Neil Duncan, Shibing Deng, & Michael W. Dunne. (2007). Azithromycin/Chloroquine Combination Does Not Increase Cardiac Instability despite an Increase in Monophasic Action Potential Duration in the Anesthetized Guinea Pig. American Journal of Tropical Medicine and Hygiene. 77(5). 929–938. 38 indexed citations
7.
Haadsma‐Svensson, Susanne R., Dac M. Dinh, J. Neil Duncan, et al.. (2001). Dopamine D3 Receptor Antagonists. 1. Synthesis and Structure−Activity Relationships of 5,6-Dimethoxy-N-alkyl- and N-Alkylaryl-Substituted 2-Aminoindans. Journal of Medicinal Chemistry. 44(26). 4716–4732. 37 indexed citations
8.
Poel, Toni J., Dac M. Dinh, Mary E. Lajiness, et al.. (1997). Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor. European Journal of Pharmacology. 322(2-3). 283–286. 21 indexed citations
9.
Heier, Richard F., Lester A. Dolak, J. Neil Duncan, et al.. (1997). Synthesis and Biological Activities of (R)-5,6-Dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and Its Metabolites. Journal of Medicinal Chemistry. 40(5). 639–646. 63 indexed citations
10.
TenBrink, Ruth E., J. Neil Duncan, Douglas W. Harris, et al.. (1996). (S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D4 Antagonist. Journal of Medicinal Chemistry. 39(13). 2435–2437. 85 indexed citations
11.
Duncan, J. Neil, et al.. (1995). The pharmacology and pharmacokinetics of vigabatrin. UCL Discovery (University College London). 7 indexed citations
13.
Haadsma‐Svensson, Susanne R., Martin Smith, J. Neil Duncan, et al.. (1994). Synthesis and biological activity of C-5 modified derivatives of (+)-AJ76 and (+)-UH232: Increased dopamine D3 receptor preference and improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 4(5). 689–694. 9 indexed citations
14.
Sonesson, Clas, Agneta Ekman, Arvid Carlsson, et al.. (1993). Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Journal of Medicinal Chemistry. 36(22). 3409–3416. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026